Pharmesis International Ltd. (SGX:BFK)
Singapore
· Delayed Price · Currency is SGD 0.4650
0.00 (0.00%)
At close: Aug 11, 2025, 5:00 PM SGT
Pharmesis International Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 70.98 | 67.65 | 45.64 | 50.37 | 52.77 | 47.11 | Upgrade
|
| Revenue Growth (YoY) | 69.75% | 48.24% | -9.40% | -4.55% | 12.01% | 26.63% | Upgrade
|
| Cost of Revenue | 45.19 | 43.5 | 24.82 | 26.36 | 27.77 | 23.25 | Upgrade
|
| Gross Profit | 25.79 | 24.15 | 20.82 | 24.01 | 25 | 23.86 | Upgrade
|
| Selling, General & Admin | 22.31 | 22.13 | 23.61 | 26.54 | 23.94 | 28.18 | Upgrade
|
| Operating Expenses | 22.24 | 22.13 | 23.61 | 26.54 | 23.94 | 28.18 | Upgrade
|
| Operating Income | 3.55 | 2.02 | -2.8 | -2.53 | 1.06 | -4.32 | Upgrade
|
| Interest Expense | -0.7 | -0.7 | -0.87 | -0.94 | -1.04 | -0.92 | Upgrade
|
| Interest & Investment Income | 0 | 0 | 0.02 | 0.03 | 0.03 | 0.04 | Upgrade
|
| Currency Exchange Gain (Loss) | 0 | 0 | 0.05 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.22 | 0.19 | -1.26 | 0.28 | 2.06 | 0.55 | Upgrade
|
| EBT Excluding Unusual Items | 3.07 | 1.53 | -4.86 | -3.16 | 2.12 | -4.65 | Upgrade
|
| Asset Writedown | 6.91 | 6.91 | - | - | - | -1.34 | Upgrade
|
| Other Unusual Items | - | - | - | - | - | 0.16 | Upgrade
|
| Pretax Income | 9.98 | 8.44 | -4.86 | -3.16 | 2.12 | -5.84 | Upgrade
|
| Income Tax Expense | -0.27 | 0.83 | 0.05 | 0.02 | 0.15 | 0.01 | Upgrade
|
| Earnings From Continuing Operations | 10.25 | 7.61 | -4.9 | -3.18 | 1.97 | -5.85 | Upgrade
|
| Minority Interest in Earnings | 0.14 | 0.67 | -0.05 | -0.38 | -0.8 | 0.02 | Upgrade
|
| Net Income | 10.39 | 8.28 | -4.96 | -3.56 | 1.17 | -5.83 | Upgrade
|
| Net Income to Common | 10.39 | 8.28 | -4.96 | -3.56 | 1.17 | -5.83 | Upgrade
|
| Shares Outstanding (Basic) | 32 | 30 | 26 | 23 | 23 | 23 | Upgrade
|
| Shares Outstanding (Diluted) | 32 | 30 | 26 | 23 | 23 | 23 | Upgrade
|
| Shares Change (YoY) | 14.12% | 13.08% | 14.85% | - | - | - | Upgrade
|
| EPS (Basic) | 0.33 | 0.28 | -0.19 | -0.15 | 0.05 | -0.25 | Upgrade
|
| EPS (Diluted) | 0.33 | 0.28 | -0.19 | -0.15 | 0.05 | -0.25 | Upgrade
|
| Free Cash Flow | 3.47 | -4.24 | -12.17 | 6.33 | -0.93 | 0.77 | Upgrade
|
| Free Cash Flow Per Share | 0.11 | -0.14 | -0.46 | 0.28 | -0.04 | 0.03 | Upgrade
|
| Gross Margin | 36.34% | 35.70% | 45.61% | 47.67% | 47.38% | 50.64% | Upgrade
|
| Operating Margin | 5.00% | 2.99% | -6.13% | -5.02% | 2.01% | -9.17% | Upgrade
|
| Profit Margin | 14.64% | 12.24% | -10.86% | -7.07% | 2.22% | -12.37% | Upgrade
|
| Free Cash Flow Margin | 4.89% | -6.26% | -26.66% | 12.56% | -1.76% | 1.64% | Upgrade
|
| EBITDA | 5.27 | 3.24 | -1.62 | -1.19 | 2.33 | -3 | Upgrade
|
| EBITDA Margin | 7.42% | 4.78% | -3.54% | -2.36% | 4.42% | -6.37% | Upgrade
|
| D&A For EBITDA | 1.72 | 1.21 | 1.18 | 1.34 | 1.27 | 1.32 | Upgrade
|
| EBIT | 3.55 | 2.02 | -2.8 | -2.53 | 1.06 | -4.32 | Upgrade
|
| EBIT Margin | 5.00% | 2.99% | -6.13% | -5.02% | 2.01% | -9.17% | Upgrade
|
| Effective Tax Rate | - | 9.80% | - | - | 7.04% | - | Upgrade
|
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.